Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 05/07/21 | 8-K | Current report filing |
|
2 | |
| 05/05/21 | EFFECT | Notice of Effectiveness |
|
1 | |
| 05/03/21 | 8-K | Current report filing |
|
55 | |
| 04/23/21 | S-3/A | Registration statement for specified transactions by certain issuers |
|
19 | |
| 04/19/21 | 8-K | Current report filing |
|
55 | |
| 04/19/21 | 8-K | Current report filing |
|
4 | |
| 04/19/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
1 | |
| 04/19/21 | 8-K | Current report filing |
|
4 | |
| 04/01/21 | S-3 | Registration statement for specified transactions by certain issuers |
|
19 | |
| 03/31/21 | DEF 14A | Definitive proxy statements |
|
21 |
